ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Jan 2026
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
February 2026
Nuclear Technology
December 2025
Fusion Science and Technology
November 2025
Latest News
Report: New recommendations for nuclear waste
Today, a bipartisan group of experts including energy consultant Lake Barrett and former NRC chair Allison Macfarlane have published a report titled The Path Forward for Nuclear Waste in the U.S.
The report recommends a new solution for managing domestic nuclear waste—one that centers around the foundation of an independent corporation led by reactor owners. Responsibility for waste management transport, storage, and disposal would be managed by this corporation rather than the Department of Energy.
Martha Hultqvist, Irena Gudowska
Nuclear Technology | Volume 168 | Number 1 | October 2009 | Pages 123-127
Dose/Dose Rate | Special Issue on the 11th International Conference on Radiation Shielding and the 15th Topical Meeting of the Radiation Protection and Shielding Division (Part 1) / Radiation Protection | doi.org/10.13182/NT09-A9111
Articles are hosted by Taylor and Francis Online.
The mathematical anthropomorphic phantoms EVA-HIT and ADAM-HIT have been used in the Monte Carlo code SHIELD-HIT07 for simulations of lung tumor and prostate irradiation with light ions. Calculations were performed for 1H, 7Li, and 12C beams of energies in the range of 80 to 330 MeV/u. The secondary doses to organs, due to scattered primary ions and secondary particles produced in the phantoms, were studied taking into account the contribution from secondary neutrons, secondary protons, pions, and heavier fragments from helium to calcium. The doses to organs per dose to target (tumor) are of the order of 10-6 to 10-1 mGy Gy-1 and decrease with increasing distance from the target. In general the organ dose per target dose increases with increasing Z of the primary particle; however, for lighter primary ions (Z 3) and for organs close to the target, scattered primary particles show a nonnegligible dose contribution.